analyzed the pattern and level of expression of IFN-I (α and β), IFN-III (λ1, λ2, λ3) and the transcriptional programs associated with the IFN landscape in the upper or lower respiratory tract of patients with varied severity of COVID-19. This evidence concerns the gene IFNA1 and COVID-19.